Bronchopleural fistula after non small cell lung cancer radiofrequency ablation: what it implying to us?

Diagnostic Pathology

Xiaofei Li¹  Qiang Lu¹  Yongan Zhou¹  Yong Han¹  Lijun Huang¹  Weimiao Li¹ 

[1]Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, China

关键词: Pathological changes;    Radiofrequency ablation;    Non–small cell lung cancer;   

Others  :  1217797
DOI  :  10.1186/1746-1596-8-202

 received in 2013-11-03, accepted in 2013-11-25,  发布年份 2013

【 摘 要 】

Radiofrequency ablation (RFA) is an alternative method to treat the inoperable NSCLC and there were few serious complications after RFA therapy have been reported. Here, we reported a NSCLC patient endured empyema after treatment by RFA for one month. There was a 20 × 25 × 20 mm mass on the right middle lobe by CT scan before RFA and a huge gas cavity with liquid was found in the right chest cavity after RFA treatment for twenty- eight days. A hole in the right middle lobe was found with large amount of pus in the pleural cavity as well as the bronchopleural fistula (BPF) during the operation. Results from the postoperative pathology showed a multiple small foci differentiated adenocarcinoma, partial bronchiolar-alveolar carcinoma, 0.5 cm away around the hole at the same time. It is difficult to diagnose and treat the rare complication of BPF, while, the larger field of ablation might be helpful to postpone the tumor local progression. Therefore, surgery was a good option for BPF especially when an empyema occurred.

【 授权许可】

   
2013 Li et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics. CA Cancer J Clin 2009, 59:225-249.
• [2]Crocetti L, Lencioni R: Radiofrequency ablation of pulmonary tumors. Eur J Radiol 2010, 75:23-27.
• [3]Kashima M, Yamakado K, Takaki H, Kodama H, Yamada T, Uraki J, Nakatsuka A: Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences. AJR Am J Roentgenol 2011, 197:W576-580.
• [4]Beljan Perak R, Durdov MG, Capkun V, Ivcevic V, Pavlovic A, Soljic V, Peric M: IMP3 can predict aggressive behaviour of lung adenocarcinoma. Diagnostic pathology 2012, 7:165. BioMed Central Full Text
• [5]Kayser G, Kassem A, Sienel W, Schulte-Uentrop L, Mattern D, Aumann K, Stickeler E, Werner M, Passlick B, zur Hausen A: Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1. Diagnostic pathology 2010, 5:22. BioMed Central Full Text
• [6]Lu Q, Lu S, Huang L, Wang T, Wan Y, Zhou CX, Zhang C, Zhang Z, Li X: The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer. Diagnostic pathology 2013, 8:145. BioMed Central Full Text
• [7]Pennathur A, Abbas G, Gooding WE, Schuchert MJ, Gilbert S, Christie NA, Landreneau RJ, Luketich JD: Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thorac Surg 2009, 88:1601-1606. discussion 1607–1608
• [8]Legras A, Mordant P, Cazes A, Riquet M: [Radiofrequency of lung metastases: Should initial pneumothorax predict treatment failure?]. Revue de pneumologie clinique; 2013.
• [9]Schoellnast H, Deodhar A, Hsu M, Moskowitz C, Nehmeh SA, Thornton RH, Sofocleous CT, Alago W Jr, Downey RJ, Azzoli CG, et al.: Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy. Acta Radiol 2012, 53(8):893-839.
• [10]Cannella M, Cornelis F, Descat E, Ferron S, Carteret T, Castagnede H, Palussiere J: Bronchopleural fistula after radiofrequency ablation of lung tumours. Cardiovasc Intervent Radiol 2011, 34(Suppl 2):S171-174.
• [11]Dupuy DE, DiPetrillo T, Gandhi S, Ready N, Ng T, Donat W, Mayo-Smith WW: Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006, 129:738-745.
• [12]Huang L, Han Y, Zhao J, Wang X, Cheng Q, Li X, Xu H, Gao K: Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? Eur J Cardiothorac Surg 2010, 39:348-351.
• [13]Sakurai J, Hiraki T, Mukai T, Mimura H, Yasui K, Gobara H, Hase S, Fujiwara H, Iguchi T, Tajiri N, et al.: Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol 2007, 18:141-145.
• [14]Kodama H, Yamakado K, Murashima S, Takaki H, Uraki J, Nakatsuka A, Shoumura S, Tarukawa T, Shimamoto A, Takao M, Takeda K: Intractable bronchopleural fistula caused by radiofrequency ablation: endoscopic bronchial occlusion with silicone embolic material. Br J Radiol 2009, 82:e225-227.
• [15]Abu-Hijleh M, Blundin M: Emergency use of an endobronchial one-way valve in the management of severe air leak and massive subcutaneous emphysema. Lung 2010, 188:253-257.
• [16]Lois M, Noppen M: Bronchopleural fistulas: an overview of the problem with special focus on endoscopic management. Chest 2005, 128:3955-3965.
• [17]Nguyen CL, Scott WJ, Young NA, Rader T, Giles LR, Goldberg M: Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest 2005, 128:3507-3511.